To be exact about it, what a useful certificate carries is debatable, but there are certain fields that almost no research-grade certificate includes despite their being standard in pharmaceutical work.
Multiple testing on the same lot reported in a single document suggests internal quality control; identical figures across different lots suggests the same certificate reused.
It helps to be literal here: a method section that differs markedly from pharmacopoeial standards is either innovative or nonstandard, and distinguishing the two requires expertise.
Industry guidance on this topic is consistent because it comes from first principles rather than convention.
One qualification: a single result from a single vial at a single time is a point estimate with no error bar, and no amount of decimal places changes that.
My working rule is that a document without a lot number, a method section and a test date is marketing.
edited 3 Dec 2025 by eoin_mcgarry — removed a claim I could not source